Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge

Kidney International

Volumn 43, Issue 4, 1993, Pages 853-864

  Silbiger, Sharon ^a   Crowley, Susan ^a   Shan, Zihe ^a   Brownlee, Michael ^a   Satriano, Joseph ^a   Schlondorff, Detlef ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MESSENGER RNA; PROTEOGLYCAN;

ANIMAL TISSUE; ARTICLE; CELL CULTURE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GLYCATION; HYPERGLYCEMIA; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; CELLS, CULTURED; COLLAGEN; DIABETIC NEPHROPATHIES; DNA; ELECTROCHEMISTRY; GLOMERULAR MESANGIUM; GLUCOSE; GLYCOSYLATION; PROTEINS; PROTEOGLYCANS; RATS; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027394591     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1993.120     Document Type: Article

References (57)

1. HOSTETTER TH: Diabetic nephropathy, in The Kidney, edited by BRENNER B, RECTOR F, Saunders Co., 1986
2. MAUER SN, STEFFES MW, ELLIS EN, SUTHERLAND DER, BROWN DM, GOETZ FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1145-1155, 1984
3. BRUNEVAL P, FOIDART JM, NOCHY D, CAMILLERI JP, BARIETY J: Glomerular matrix proteins in modular glomerulosclerosis in association with light chain deposition disease and diabetes mellitus. Hum Pathol 16:477-484, 1985
4. KARTTHUNEN TJ, RISTELI J, AUTIO-HARMAINEN H, RISTELI L: Effect of age and diabetes on type IV collagen and laminin in human kidney cortex. Kidney Int 30:586-591, 1986
5. KIM Y, KLEPPEL MM, BUTKOWSKI R, MAUER SM, WEISLANDER J, MICHAEL A: Differential expression of basement membrane collagen chains in diabetic nephropathy. Am J Pathol 138:413-420, 1991
6. ABRASS CK, PETERSON CV, RAUGI GS: Phenotypic expression of collagen types in mesangial matrix of diabetic and nondiabetic rats. Diabetes 37:1695-1702, 1988
7. NICHOLLS K, MANDEL TE: Advanced glycosylation end-products in experimental murine diabetic nephropathy: Effect of islet isografting and of aminoguanidine. Lab Invest 60:486-491, 1989
8. CHARONIS AS, REGER LA, DEGE JE, KOUZI-KOLIAKOS K, FURCHT LT, WOHLHUETER RM, TSILIBARY EC: Laminin alterations after in vitro nonenzymatic glycosylation. Diabetes 39:807-814, 1990
9. COHEN MP, Ku L: Inhibition of fibronectin binding to matrix components by nonenzymatic glycosylation. Diabetes 33:970-974, 1984
10. BROWNLEE M, VLASSARA H, CERAMI A: Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein. Diabetes 34:938-941, 1985
11. BROWNLEE M, VLASSARA H, CERAMI A: Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Annal Int Med 101:527-537, 1984
12. AYO SH, RADNIK RA, GLASS WF, II, GARONI JA, RAMPT ER, APPLING DR, KREISBERG JI: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260 (29):F185-F191, 1991
13. ZIYADEH FN, SNIPES ER, WATANABE M, ALVAREZ RJ, GOLDFARB S, HAVERTY TP: High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am J Physiol 259 (28):F704-F714, 1990
14. SILBIGER SR, SCHLONDORFF D, GORDON P: Effect of glucose on proteoglycan production in rat mesangial cells in culture, (abstract) Kidney Int 37:223, 1990
15. POULSOM R, KURKINEN M, PROCKOP DJ, BOOT-HANDFORD RP: Increased steady-state levels of laminin B1 mRNA in kidneys of long-term streptozotocin-diabetic rats. J Biol Chem 263 (21): 10072-10078, 1988
16. FALK RJ, SCHEINMAN JI, MAUER SM, MICHAEL AF: Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes 32 (Suppl 2):34-39, 1983
17. CROWLEY S, BROWNLEE M, SINGHAL P, EDELSTEIN D, SCHLONDORFF D: Effects of nonenzymatic glycosylation of mesangial matrix on proliferation of mesangial cells. Diabetes 40(5):40-47, 1991
18. SCHLONDORFF D, GOLDWASSER P, NEUWIRTH R, SATRIANO JA, CLAY K: Production of platelet activating factor in glomeruli and cultured glomerular mesangial cells. Am J Physiol 250:F1123-F1127, 1986
19. WEISS SR, REGIANI S: Neutrophils degrade subendothelial matrices in the presence of alpha-1-proteinase inhibitor. Comparative use of lysosomal proteinases and oxygen metabolites. J Clin Invest 73:1297-1303, 1984
20. KOHN RR, CERAMI A, MONNIER VM: Collagen ageing in vitro by nonenzymatic glycosylation and browning. Diabetes 33:57-59, 1984
21. FORTH AJ: Methods for assaying nonenzymatic glycosylation. Anal Biochem 175:347-360, 1988
22. BROWNLEE M, VLASSARA H, KOONEY A, ULRICH P, CERAMI A: Inhibition of diabetes-induced arterial wall lipoprotein deposition and prevention of arterial wall collagen crosslinking by aminoguanidine. (abstract) Diabetologia 29:523A, 1986
23. WEST DC, SATTAR A, KUMAR S: Simplified in situ solubilization procedure for the determination of DNA and cell number in tissue cultured mammalian cells. Anal Biochem 147:289-295, 1985
24. PETERKOFSKY B, DIEGELMANN R: Use of a mixture of proteinasefree collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochem 10:988-994. 1971
25. SAGE H, BORNSTEIN P: Preparation and characterization of procollagens and procollagen-collagen intermediates. Meth Enzymol 82: 96-122, 1982
26. BITTER T, MUIR H: A modified uronic acid carbazole reaction. Anal Biochem 4:330-334, 1962
27. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
28. THOMAS PS: Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 77:5201-5205, 1980
29. MYERS JC, CHU M, FARO SH, CLARK WJ, PROCKOP DJ, RAMIREZ F: Cloning a cDNA for the pro-alpha 2 chain of human type 1 collagen. Proc Natl Acad Sci USA 78:3516-3520, 1981
30. OBERBAUMER I, LAURENT M, SCHWARTZ U, SAKURAI Y, YAMADA Y, VOGELI G, Voss T, SIEBOLD B, GLANVILLEE RW, KUHN K: Amino acid sequence of the non-collagenous globular domain (NC1) of the alpha 1 (IV) chain of basement membrane collagen as derived from complementary DNA. Eur J Biochem 147:217-224, 1985
31. DERYNCK R, JARRETT JA, CHEN EY, GOEDDEL DV: The murine transforming growth factor-B precursor. J Biol Chem 261:4377-4379, 1986
32. FISHER LW, TERMINE JD, YOUNG MR: Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem 264:4571-4576, 1989
33. YUN J, SUN X-H, KAO T-H, REECE KS, WU R: Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene +. Nucl Acid Res 13:2485-2502, 1985
34. FEINBERG AP, VOGELSTEIN B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13, 1983
35. BROWNLEE M, VLASSARA H, KOONEY A, ULRICH P, CERAMI A: Amino-guanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232:1629-1632, 1986
36. SEETHARAMA A, MANNING JM: Reaction of glycolaldehyde with proteins: Latent crosslinking potential of alpha-hydroxyaldehydes. Proc Natl Acad Sci USA 80:3590-3594, 1983
37. SCHWARTZ E, BIENKOWSKI RS, COLTOFF-SCHILLER B, GOLDFISCHER S, BLUMENFELD O: Changes in the components of extracellular matrix and in growth properties of cultured aortic smooth muscle cells upon ascorbate feeding. J Cell Biol 92:462-470, 1982
38. CHEN MS, HUTCHINSON ML, PECORARO RE, LEE WY, LABBE RF: Hyperglycemia-induced intracellular depletion of ascorbic acid in human mononuclear leukocytes. Diabetes 32:1078-1081, 1983
39. KLEIN DJ, BROWN DM, KIM Y, OEGEMA TR JR: Proteoglycans synthesized by human glomerular mesangial cells in culture. J Biol Chem 265:9533-9543, 1990
40. YAOITA E, OGURI K, OKAYAMA E, KAWASAKI K, KOBAYASHI S, KIHARA I, OKAYAMA M: Isolation and characterization of proteoglycans synthesized by cultured mesangial cells. J Biol Chem 265:522-531, 1990
41. HEINEGARD D, SOMMARIN Y: Proteoglycans: An overview. Meth Enzymol 144:305-373, 1987
42. NATHAN C, SPORN M: Cytokines in context. J Cell Biol 113:981-986, 1991
43. STANKOVA L, RIDDLE M, LARNED J, BURRY K, MENASHE D, HART J, BIGLEY R: Plasma ascorbate concentrations and blood cell dehydroascorbate transport in patients with diabetes mellitus. Metabolism 33:347-353, 1984
44. MCLEENAN S, YUE D, FISHER E, CAPOGRECO C, HEFFERMAN S, ROSS G, TURTLE J: Deficiency of ascorbic acid in experimental diabetes. Relationship with collagen and polyol pathway abnormalities. Diabetes 37:359-361, 1988
45. STERZEL RB, LOVETT DM, FOELLMER HG, PERFETTO M, BIEMESDERFER D, KASHGARIAN M: Mesangial cell hillocks: Nodular foci of exaggerated growth of cells and matrix in prolonged culture. Am J Pathol 125:130-140, 1986
46. ROBERTS AB, FLANDERS KC, KONDAIAH P, THOMPSON NL, VAN OBBERGHEN-SCHILLING E, WAKEFIELD L, ROSSI P, DE CROMBRUGGIE B, HEINE U, SPORN MB: Transforming growth factor beta. Recent Progr Hormone Res 44:157-197, 1988
47. OKUDA S, LANGUINO LR, RUOSLAHTI E, BORDER WA: Elevated expression of transforming growth factor-B and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86:453-462, 1990
48. LEDBETTER S, COPELAND EJ, NOONAN D, VOGELI G, HASSELL JR: Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthase inhibition. Diabetes 39:196-203, 1990
49. HASSLACHER C, KOPESCHKE HG, BRUKLIN E, GECHTER F, REICHENBACHER R: In vivo studies on biosynthesis in diabetic and nondiabetic rats. Res Exp Med 181:245-251, 1982
50. Wu V-Y, WILSON B, COHEN MP: Disturbances in glomerular basement membrane glycosaminoglycans in experimental diabetes Diabetes 36:679-683, 1987
51. COHEN MP, KLEPSER H, Wu V-U: Undersulfation of glomerular basement membrane heparan sulfate in experimental diabetes and lack of correction with aldose reductase inhibition. Diabetes 37: 1324-1327, 1988
52. TAMSMA JT, BRUIJN JA, ASSMANN KJM, WEENING JJ, BORN J, BERDEN JHM, SCHRAMA E, LEMKES HHPJ, WOUDE FJ: Decreased expression of glomerular HSPG-GAG in diabetic nephropathy. (abstract) J Am Soc Nephrol 2 (3):299, 1991
53. 4 proteoglycans in streptozocin-induced diabetic rats. Diabetes 35:1130-1142, 1986
54. 4 proteoglycan by heparin from glomeruli of streptozocin-induced diabetic rats. Diabetes 38:130-139, 1989
55. MORAN A, BROWN D, KERN Y, KLEIN D: Effect of IGF-1 and glucose on protein and proteoglycan synthesis by human fetal mesangial cells in culture. Diabetes 40:1346-1354, 1991
56. STAMATOGLOU SC, KELLER JM: Interaction of cellular glycosaminoglycans with plasma fibronectin and collagen. Biochim Biophys Acta 719:90-97, 1982
57. OLDBERG A, RUOSLAHTI E: Interactions between chondroitin sulfate proteoglycan, fibronectin and collagen. J Biol Chem 257: 4859-4863, 1982